StockpollyBeta
Get App
Popularity #4,045
BNGO · NASDAQ · Medical - Instruments & Supplies

Bionano Genomics (BNGO)

Optical genome mapping systems, software and consumables for structural-variation analysis.

$1.77
vs last close−0.05 (−2.75%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue9119868677878
Cost of revenue7865155434534
Gross profit3233−83333334
1162234203515111112121112
Research & development141210753233333
2511200912989989
General & administrative000000000009
Other expenses770413210000000
Operating income−113−20−31−17−44−12−8−8−9−9−8−7
1−24010−8510100
Interest income111000000000
Interest expense050000000000
Other non-operating income−119−4−108−5−10−100
Income before tax−113−44−31−16−44−20−3−7−8−8−8−7
Income tax expense000000000000
Net income from continuing operations−113−44−31−16−44−20−3−7−9−8−8−7
Net income−113−44−31−16−44−20−3−7−9−8−8−7
EPS, basic−$11,577.60−$57.56−$35.75−$14.40−$30.92−$10.79−$1.15−$1.99−$1.59−$0.74−$0.76−$0.64
EPS, diluted−$11,577.60−$57.56−$35.75−$14.40−$30.92−$10.79−$1.15−$1.99−$1.59−$0.74−$0.76−$0.64
Weighted average shares, basic111112335111112
Weighted average shares, diluted111112335111112
EBITDA−109−35−24−13−38−18−1−4−6−5−6−5
Depreciation & amortization443362222222
EBIT−112−39−27−16−44−20−3−7−8−8−8−7